| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Roberto Stasi | Q124077304 |
| P2093 | author name string | Robert Lowe | |
| Muriel S Shannon | |||
| Pallavi Kalkur | |||
| Lian Wea Chia | |||
| P2860 | cites work | Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia | Q27488342 |
| Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection | Q27490427 | ||
| Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium | Q29619747 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Natural history of chronic hepatitis C | Q29620673 | ||
| Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation | Q33328502 | ||
| Autoimmune thrombocytopenia associated with hepatitis C virus infection | Q33502899 | ||
| Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations | Q33502986 | ||
| Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. | Q33504098 | ||
| Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? | Q33504413 | ||
| Epidemiology and prevention of hepatitis B. | Q33964707 | ||
| Hemophagocytic syndrome associated with hepatitis A: case report and literature review | Q37167250 | ||
| Virus-Associated Hemophagocytic Syndrome related to acute CMV and HBV sexual co-infection: a case report | Q40383589 | ||
| Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide | Q40493029 | ||
| Fatal virus-associated hemophagocytic syndrome associated with coexistent chronic active hepatitis B and acute hepatitis C virus infection | Q40637435 | ||
| Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection | Q42978693 | ||
| The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines | Q43034754 | ||
| Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center | Q43049522 | ||
| Idiopathic thrombocytopenic purpura with acute hepatitis C viral infection | Q73165602 | ||
| Hemophagocytic syndrome associated with fulminant hepatitis A: a case report | Q73313124 | ||
| Thrombopoietin | Q77218573 | ||
| Severe thrombocytopenia in association with hepatitis A | Q81125274 | ||
| Virus-associated idiopathic thrombocytopenic purpura | Q33329009 | ||
| Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. | Q33331309 | ||
| HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy | Q33333436 | ||
| Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease | Q33334842 | ||
| Thrombocytopenia in liver disease | Q33335386 | ||
| Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis | Q33337510 | ||
| Treatment of hepatitis C related thrombocytopenia with interferon alpha | Q33340288 | ||
| Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection | Q33341932 | ||
| Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection | Q33343858 | ||
| Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis | Q33344948 | ||
| Hepatitis A virus infection associated with hemophagocytic syndrome: report of two cases | Q33346021 | ||
| Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases | Q33346990 | ||
| Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases | Q33348054 | ||
| Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. | Q33359563 | ||
| Extrahepatic manifestations of viral hepatitis | Q33361863 | ||
| Thrombocytopenia in hepatitis A--an atypical presentation | Q33362534 | ||
| The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. | Q33366601 | ||
| Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura | Q33366747 | ||
| Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulin. | Q33367751 | ||
| Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia | Q33368703 | ||
| Management of the hematologic complications of hepatitis C therapy | Q33368815 | ||
| Extrahepatic manifestations of hepatitis C. | Q33369289 | ||
| Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A. | Q33370601 | ||
| Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia | Q33372989 | ||
| Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B. | Q33377506 | ||
| Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. | Q33377599 | ||
| Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura | Q33377602 | ||
| Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura | Q33379498 | ||
| Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias | Q33383466 | ||
| Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia | Q33470082 | ||
| Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets | Q33494406 | ||
| Hepatitis C virus infection and autoimmune thrombocytopenic purpura | Q33496566 | ||
| High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. | Q33497218 | ||
| Thrombocytopenia associated with hepatitis C viral infection | Q33497636 | ||
| P433 | issue | 3 | |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | e2009023 | |
| P577 | publication date | 2009-11-25 | |
| P1433 | published in | Mediterranean journal of hematology and infectious diseases | Q27723406 |
| P1476 | title | Pathobiology and treatment of hepatitis virus-related thrombocytopenia | |
| P478 | volume | 1 |
| Q26849334 | Eltrombopag in chronic hepatitis C |
| Q90633656 | Extrahepatic manifestations of hepatitis E virus: An overview |
| Q26997803 | Human platelets and their capacity of binding viruses: meaning and challenges? |
| Q43160602 | Immune Thrombocytopenic Purpura Associated with Hepatitis A Infection in a Five-year Old Boy: A Case Report |
| Q91451866 | Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice |
Search more.